An agenda for UK clinical pharmacology: Developing and delivering clinical pharmacology in pharmaceutical companies
Article first published online: 8 MAY 2012
DOI: 10.1111/j.1365-2125.2012.04227.x
© 2012 The Author. British Journal of Clinical Pharmacology © 2012 The British Pharmacological Society
Issue

British Journal of Clinical Pharmacology
Special Issue: Agenda for Clinical Pharmacology Issue
Volume 73, Issue 6, pages 870–873, June 2012
Additional Information
How to Cite
Richards, D. (2012), An agenda for UK clinical pharmacology: Developing and delivering clinical pharmacology in pharmaceutical companies. British Journal of Clinical Pharmacology, 73: 870–873. doi: 10.1111/j.1365-2125.2012.04227.x
Publication History
- Issue published online: 8 MAY 2012
- Article first published online: 8 MAY 2012
- Accepted manuscript online: 23 FEB 2012 04:50AM EST
- RECEIVED; January 2012; ACCEPTED; 30 January 2012; ACCEPTED ARTICLE PUBLISHED ONLINE; 23 February 2012
- Abstract
- Article
- References
- Cited By
The challenges of developing new medicines are well known. Effective application of clinical pharmacology expertise is vital to the successful evaluation of potential new medicines. In drug development, this depends on effective integration of diverse skills. Many of these are currently in short supply, but through innovative partnerships between industry and academia there is an opportunity to reinvigorate the discipline by nurturing these key skills to the benefit of both partners. Specific areas of focus should be experimental medicine, modelling and simulation, and translational skills.

1365-2125/asset/olbannerleft.gif?v=1&s=e86b92cac3efbbd2e255b9fa97ece9623eac0b54)
1365-2125/asset/olbannerright.gif?v=1&s=6a7c47d290382bf3bc40c62461bc36a371a081bf)